Active, Not Recruiting
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
NCT04586231
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Ironwood Cancer & Research Centers ( Site 0077) Chandler, Arizona, United States
- Cedars Sinai Medical Center ( Site 0027) Los Angeles, California, United States
- UCLA Hematology/Oncology - Santa Monica ( Site 0048) Los Angeles, California, United States
- St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0095) Orange, California, United States